Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21366475 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
Conditions: Schizoaffective Disorder;   Schizophrenia
Interventions: Drug: IM risperidone;   Drug: oral antipsychotic medication

Indicates status has not been verified in more than two years